Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Glioblastoma Treatment Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Glioblastoma Treatment Drugsmarket, defines the market attractiveness level of Glioblastoma Treatment Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Glioblastoma Treatment Drugs industry, describes the types of Glioblastoma Treatment Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Glioblastoma Treatment Drugs market and the development prospects and opportunities of Glioblastoma Treatment Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Glioblastoma Treatment Drugs market in Chapter 13.
By Player:
Bristol Myers Squibb Company
Sandoz
Merck & Co
Arbor Pharms LLC
Emcure Pharmaceuticals Ltd
Sigma Tau Pharmaceuticals
F Hoffmann La Roche AG
By Type:
VEGF/VEGFR Inhibitor
Alkylating Agents
Miscellaneous Antineoplastic
By End-User:
Hospital
Cancer Research Organization
Long Term Care Center
Diagnostic Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Glioblastoma Treatment Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Glioblastoma Treatment Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Glioblastoma Treatment Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Glioblastoma Treatment Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Glioblastoma Treatment Drugs Market Analysis and Outlook to 2022
-
7.1 Global Glioblastoma Treatment Drugs Consumption (2017-2022)
-
7.2 United States Glioblastoma Treatment Drugs Consumption (2017-2022)
-
7.3 Europe Glioblastoma Treatment Drugs Consumption (2017-2022)
-
7.4 China Glioblastoma Treatment Drugs Consumption (2017-2022)
-
7.5 Japan Glioblastoma Treatment Drugs Consumption (2017-2022)
-
7.6 India Glioblastoma Treatment Drugs Consumption (2017-2022)
-
7.7 South Korea Glioblastoma Treatment Drugs Consumption (2017-2022)
8 Region and Country-wise Glioblastoma Treatment Drugs Market Analysis and Outlook to 2028
-
8.1 Global Glioblastoma Treatment Drugs Consumption Forecast (2022-2028)
-
8.2 United States Glioblastoma Treatment Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Glioblastoma Treatment Drugs Consumption Forecast (2022-2028)
-
8.4 China Glioblastoma Treatment Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Glioblastoma Treatment Drugs Consumption Forecast (2022-2028)
-
8.6 India Glioblastoma Treatment Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Glioblastoma Treatment Drugs Consumption Forecast (2022-2028)
9 Global Glioblastoma Treatment Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Glioblastoma Treatment Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global VEGF/VEGFR Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Alkylating Agents Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Miscellaneous Antineoplastic Consumption and Growth Rate (2017-2022)
-
9.2 Global Glioblastoma Treatment Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Research Organization Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Long Term Care Center Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
10 Global Glioblastoma Treatment Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Glioblastoma Treatment Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global VEGF/VEGFR Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Alkylating Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Miscellaneous Antineoplastic Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Glioblastoma Treatment Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Research Organization Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Long Term Care Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Glioblastoma Treatment Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Glioblastoma Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Glioblastoma Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Glioblastoma Treatment Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Glioblastoma Treatment Drugs Market Competitive Analysis
-
14.1 Bristol Myers Squibb Company
-
14.1.1 Bristol Myers Squibb Company Company Details
-
14.1.2 Bristol Myers Squibb Company Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bristol Myers Squibb Company Glioblastoma Treatment Drugs Product and Service
-
14.2 Sandoz
-
14.2.1 Sandoz Company Details
-
14.2.2 Sandoz Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sandoz Glioblastoma Treatment Drugs Product and Service
-
14.3 Merck & Co
-
14.3.1 Merck & Co Company Details
-
14.3.2 Merck & Co Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck & Co Glioblastoma Treatment Drugs Product and Service
-
14.4 Arbor Pharms LLC
-
14.4.1 Arbor Pharms LLC Company Details
-
14.4.2 Arbor Pharms LLC Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Arbor Pharms LLC Glioblastoma Treatment Drugs Product and Service
-
14.5 Emcure Pharmaceuticals Ltd
-
14.5.1 Emcure Pharmaceuticals Ltd Company Details
-
14.5.2 Emcure Pharmaceuticals Ltd Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Emcure Pharmaceuticals Ltd Glioblastoma Treatment Drugs Product and Service
-
14.6 Sigma Tau Pharmaceuticals
-
14.6.1 Sigma Tau Pharmaceuticals Company Details
-
14.6.2 Sigma Tau Pharmaceuticals Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sigma Tau Pharmaceuticals Glioblastoma Treatment Drugs Product and Service
-
14.7 F Hoffmann La Roche AG
-
14.7.1 F Hoffmann La Roche AG Company Details
-
14.7.2 F Hoffmann La Roche AG Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 F Hoffmann La Roche AG Glioblastoma Treatment Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Glioblastoma Treatment Drugs
-
Figure Glioblastoma Treatment Drugs Picture
-
Table Global Glioblastoma Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Glioblastoma Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Glioblastoma Treatment Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Glioblastoma Treatment Drugs Consumption by Country (2017-2022)
-
Figure United States Glioblastoma Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Glioblastoma Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Glioblastoma Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Glioblastoma Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Glioblastoma Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Glioblastoma Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Glioblastoma Treatment Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Glioblastoma Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Glioblastoma Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Glioblastoma Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Glioblastoma Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Glioblastoma Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Glioblastoma Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global VEGF/VEGFR Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Alkylating Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Miscellaneous Antineoplastic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Organization Consumption and Growth Rate (2017-2022)
-
Figure Global Long Term Care Center Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
Figure Global VEGF/VEGFR Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alkylating Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Miscellaneous Antineoplastic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Organization Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long Term Care Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Glioblastoma Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Glioblastoma Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Bristol Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol Myers Squibb Company Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol Myers Squibb Company Glioblastoma Treatment Drugs Product and Service
-
Table Sandoz (Foundation Year, Company Profile and etc.)
-
Table Sandoz Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sandoz Glioblastoma Treatment Drugs Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Glioblastoma Treatment Drugs Product and Service
-
Table Arbor Pharms LLC (Foundation Year, Company Profile and etc.)
-
Table Arbor Pharms LLC Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Arbor Pharms LLC Glioblastoma Treatment Drugs Product and Service
-
Table Emcure Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)
-
Table Emcure Pharmaceuticals Ltd Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emcure Pharmaceuticals Ltd Glioblastoma Treatment Drugs Product and Service
-
Table Sigma Tau Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Sigma Tau Pharmaceuticals Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sigma Tau Pharmaceuticals Glioblastoma Treatment Drugs Product and Service
-
Table F Hoffmann La Roche AG (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann La Roche AG Glioblastoma Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann La Roche AG Glioblastoma Treatment Drugs Product and Service
-
